News
New Weight-Loss Drugs Are Sending a Surprising Number of Americans to the Emergency Room
Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found that tens of thousands of Americans have ended up in the emergency room from taking semaglutide over the past few years.
Novo Nordisk is racing to capture more patients now that many compounding pharmacies are restricted from making Wegovy ...
Mounjaro, initially for type 2 diabetes, gains popularity for weight loss, yet users report severe side effects. Ellie Marie, ...
Novo Nordisk A/S is partnering with telehealth companies including Hims & Hers Health Inc., LifeMD Inc., and Ro to offer ...
Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of ...
A self-confessed “borderline alcoholic” says weight loss jabs helped her lose 85 pounds by curbing her alcohol cravings – and ...
Studies in neuroscience with applications to humans offer clues about what makes us start eating, and when we stop.
While these medications offer unprecedented health benefits, they come with challenges like cost, non-adherence and lack of ...
Eli Lilly, the drugmaker with two weight-loss bestsellers, just got its first dose of healthy skeptism during a time when the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback